22 December 2025
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans GSK plc (LSE/NYSE: GSK)…
Enhertu granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer Tenth Breakthrough Therapy Designation for AstraZeneca and…
Update on LATIFY Phase III trial of ceralasertib plus Imfinzi in previously treated advanced non-small cell lung cancer The LATIFY Phase III trial of ceralasertib in…
18 December 2025
HARWORTH GROUP PLC (‘Harworth’ or the ‘Group’ or the ‘Company’) Harworth secures 267,000 sq ft of I&L Investment Portfolio lettings, delivering £2.5m of annualised…
17 December 2025
LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN INDIA GROWTH & INCOME PLC FINAL RESULTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025 Legal Entity Identifier: 549300OHW8R1C2WBYK02 Information…
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma · Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients…
16 December 2025
Full Year Results for the year ended 30 September 2025 Resilient FY25 performance with £2bn of future pipeline opportunities The Group announces its annual…
GOODWIN PLC CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS for the half year ended 31st October 2025 CHAIRMAN’S STATEMENT The Board reports a solid trading performance…